These reports suggest that hot flashes may be more common in certain individuals, particularly those who are sensitive to changes in body temperature or who have a history of hot flashes
If you are switching from one to another, there is a proper process for it, covered further down
[13] [7] If you experience any suspected side effects from medication, report them through the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk)
Julie Gralow, chief medical officer of ASCO
The label frames this as a graduated concept: begin at the lowest dose so the body can adapt to GLP-1 pathway activation, then increase under prescriber supervision according to tolerability and response
The tirzepatide 60 mg complete guide covers the highest-dose end of the spectrum, which is typically reserved for patients well into their treatment journey